Form D · Other Technology
Redivus Health, Inc.
Overland Park, KS · CIK 0001705893
Offering snapshot reported Mar 8, 2024 · SEC filing
- Reported sold
- $276K Offering amount: $1.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 28, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 8, 2024 | Initial | $276,250 | No comparison | 2 | SEC filing |
| Dec 22, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 2, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 31, 2017 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| May 5, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-507029
Source: Form D, filed Mar 8, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Dunn | Director, Executive |
| Jeff Dunn | Director, Executive |
| Anthony Fangman | Director |
| Chad Wolf | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
5440 W. 110 Th St. Suite 300
Overland Park, KS, 66211
Overland Park, KS, 66211